Abstract
Much is known about the pathogenesis of MG. This information has provided a rational basis for treatment of the disease, which is very effective. On the other hand, present treatments are limited by significant adverse effects. Our knowledge of pathogenesis also provides clues for the development of new, effective, but less toxic treatments. In addition, knowledge of the autoimmune mechanisms in MG may be useful in devising better treatments for the many human autoimmune diseases that are less well understood.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 106-110 |
| Number of pages | 5 |
| Journal | Seminars in Neurology |
| Volume | 14 |
| Issue number | 2 |
| State | Published - 1994 |
ASJC Scopus subject areas
- Clinical Neurology
- Neuroscience(all)
Fingerprint Dive into the research topics of 'Myasthenia gravis: Pathogenesis and treatment'. Together they form a unique fingerprint.
Cite this
Richman, D. P., & Agius, M. A. (1994). Myasthenia gravis: Pathogenesis and treatment. Seminars in Neurology, 14(2), 106-110.